Showing results (51-60 of 1,348) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|April 30, 2016
In vitro dissolution and in vivo bioequivalence evaluation of two brands of trimetazidine tabletsSally A Helmy, Noha O MansourClinical Pharmacology in Drug Development|April 30, 2016
Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine-1-phosphate receptor modulator, in healthy volunteersJianfeng Xu, Frank Gray, Alex Henderson, et al.Clinical Pharmacology in Drug Development|April 30, 2016
Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler deviceTeddy Kosoglou, James Hubbell, Amy O Johnson-Levonas, et al.Clinical Pharmacology in Drug Development|April 30, 2016
Evaluation of the pharmacokinetics and pharmacodynamics of two leuprolide acetate 45 mg 6-month depot formulations in patients with prostate cancerNael M Mostafa, Kristof Chwalisz, Lois Larsen, et al.Clinical Pharmacology in Drug Development|May 4, 2016
Electrocardiographic Effects of a Supratherapeutic Dose of OritavancinJay W Mason, S Eralp Bellibas, Nuo-Yu Huang, et al.Clinical Pharmacology in Drug Development|May 4, 2016
Clinical Experience With Desvenlafaxine in Treatment of Patients With Fibromyalgia SyndromeRob Allen, Uma Sharma, Suna BarlasClinical Pharmacology in Drug Development|May 4, 2016
Relative bioavailability and the effect of meal type and timing on the pharmacokinetics of migalastat in healthy volunteersFranklin K Johnson, Paul N Mudd, Salim G JanmohamedClinical Pharmacology in Drug Development|May 4, 2016
Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patientsKevin M Koch, Geraldine Ferron-Brady, Colleen Lemmon, et al.Clinical Pharmacology in Drug Development|May 4, 2016
Population pharmacokinetic analysis of thrombomodulin alfa to support dosing rationale in patients with renal impairmentMohamad-Samer Mouksassi, Jean-Francois Marier, Leon Bax, et al.Clinical Pharmacology in Drug Development|April 30, 2016
Effects of omeprazole and ritonavir on absorption and elimination of the hepatitis C virus NS5A inhibitor GSK2336805 in healthy adultsKimberly K Adkison, Lori S Jones, Yu Lou, et al.Pageof 135